MAR 26, 2020 9:00 AM PDT

Cutting Edge Viral and Non-Viral Delivery Platforms for T-Cell Engineering and Beyond

Speaker
  • Senior R&D manager, Thermo Fisher Scientific
    Biography
      Namritha Ravinder, is a Senior R&D manager at Thermo Fisher Scientific in Carlsbad, California. Dr. Ravinder and her team is focused on developing platforms and workflows for Cell and Gene therapy applications including gene delivery and viral vector systems. Prior to her current role she lead product development initiatives around mammalian genome editing and functional genomics screening as well as helped establish a variety of custom service offerings within Thermo Fisher Scientific including cDNA library generation, virus production, gene expression profiling and custom RNAi screening tools. She earned her Doctorate in Biotechnology from University of Alabama in Huntsville followed by a Postdoctoral research at Children's Hospital in Los Angeles in HIV Virology.
      https://www.linkedin.com/in/namritha-ravinder-94597559

    Abstract
    DATE:  March 26, 2020
    TIME:   9:00am PST, 12:00pm EST
     
    Growing demand for precision therapy and the recent successes with CAR-T cells for cancer treatment has put the spot light on Cell and Gene Therapy Applications. However, the difficulty of delivering relevant payloads into immune and other challenging cells remains to be a major bottle neck to rapid advancement from bench to clinic. Most studies have been focused on using viruses to engineer T cells. At the same time due to safety concerns with viral vectors there is also lot of demand and investment in non-viral based methods to maximize gene editing efficiencies in immune cells especially to meet increasing demand for developing allogeneic immune cell therapies.
     
    This talk will cover recent advancements we have made in delivery tools for genome editing, immune cell engineering and in vivo delivery applications. More specifically we will be addressing the following 4 focus areas.
     
    • Nucleic acid delivery solutions for hard-to-transfect primary & immune cell 
    • Delivery of genome editing tools like CRISPR-Cas9 with electroporation or transfection reagents
    • Scalable and high yield Lentivirus production platform for cell and gene therapy applications
    • In vivo delivery of mRNA and siRNA with Invivofectamine™ reagents.
     
    Learning Objectives:
    • Understand the difference between viral and non-viral delivery methods
    • Discover new technologies for T-Cell Engineering
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more